AU
UK
CA
NZ
IND
US
Last update at 2026-06-04T09:47:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Diploma's (LON:DPLM) five-year earnings growth trails the 25% YoY shareholder returns
Mon 21 Jul 25, 05:27 AMDiploma PLC's (LON:DPLM) Intrinsic Value Is Potentially 25% Below Its Share Price
Mon 10 Mar 25, 09:21 AMDiploma's (LON:DPLM) Dividend Will Be Increased To £0.42
Sat 11 Jan 25, 07:32 AMDeclining Stock and Solid Fundamentals: Is The Market Wrong About Diploma PLC (LON:DPLM)?
Wed 01 Jan 25, 06:06 AMAre Diploma PLC (LON:DPLM) Investors Paying Above The Intrinsic Value?
Mon 30 Sep 24, 10:59 AMWasatch International Growth Hones in on Munters Group AB with a 1.75% Portfolio Stake
Wed 14 Feb 24, 06:46 AM| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
| Income before tax | 248.30M | 176.60M | 155.60M | 129.50M | 96.60M |
| Minority interest | -0.60000M | -0.70000M | -0.60000M | -0.70000M | 0.10M |
| Net income | 184.90M | 129.30M | 117.70M | 94.70M | 69.80M |
| Selling general administrative | - | - | - | 204.30M | 160.20M |
| Selling and marketing expenses | - | - | - | 25.90M | 23.90M |
| Gross profit | 377.70M | 628.90M | 542.30M | 374.50M | 288.40M |
| Reconciled depreciation | 30.50M | 32.20M | 28.60M | 23.90M | 20.70M |
| Ebit | 276.40M | 204.50M | 230.40M | 144.30M | 104.30M |
| Ebitda | 368.60M | 296.10M | 259.00M | 163.90M | 123.40M |
| Depreciation and amortization | 92.20M | 91.60M | 28.60M | 19.60M | 19.10M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 310.70M | 207.40M | 183.30M | 144.30M | 104.30M |
| Other operating expenses | 1213.80M | 1156.00M | 1014.50M | 868.50M | 683.10M |
| Interest expense | 28.10M | 27.90M | 19.40M | 10.50M | 6.00M |
| Tax provision | 62.80M | 46.60M | 37.30M | 34.10M | 26.90M |
| Interest income | 0.80M | 0.90M | 0.80M | 0.10M | 6.80M |
| Net interest income | -27.30000M | -27.00000M | -27.70000M | -14.80000M | -7.60000M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 62.80M | 46.60M | 37.30M | 34.10M | 26.90M |
| Total revenue | 1524.50M | 1363.40M | 1200.30M | 1012.80M | 787.40M |
| Total operating expenses | 67.00M | 421.50M | 356.50M | 230.20M | 184.10M |
| Cost of revenue | 1146.80M | 734.50M | 658.00M | 638.30M | 499.00M |
| Total other income expense net | -62.40000M | -30.80000M | -27.70000M | -14.80000M | -7.70000M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 185.50M | 130.00M | 118.30M | 95.40M | 69.70M |
| Net income applicable to common shares | - | - | - | 94.70M | 69.80M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
| Total assets | 1856.80M | 1772.10M | 1589.30M | 1379.00M | 983.40M |
| Intangible assets | 482.10M | 510.40M | 524.30M | 459.10M | 348.30M |
| Earning assets | - | - | - | - | - |
| Other current assets | - | 46.40M | - | 169.90M | 129.10M |
| Total liab | 862.60M | 877.40M | 687.30M | 710.80M | 442.40M |
| Total stockholder equity | 989.70M | 888.00M | 895.60M | 662.00M | 536.30M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 10.90M | 30.80M | 12.70M | 30.80M | 11.70M |
| Common stock | 6.80M | 6.80M | 6.80M | 6.30M | 6.30M |
| Capital stock | 6.80M | 6.80M | 6.80M | 6.30M | 6.30M |
| Retained earnings | 588.00M | 478.20M | 424.40M | 375.10M | 329.10M |
| Other liab | - | - | - | 50.80M | 39.20M |
| Good will | 563.50M | 541.10M | 439.10M | 372.30M | 260.70M |
| Other assets | - | - | - | 6.60M | 0.40M |
| Cash | 81.70M | 55.50M | 62.40M | 41.70M | 24.80M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 298.30M | 271.20M | 236.50M | 263.50M | 176.40M |
| Current deferred revenue | - | - | 16.60M | - | 10.00M |
| Net debt | 383.20M | 496.60M | 334.90M | 398.00M | 229.70M |
| Short term debt | 14.40M | 13.10M | 15.30M | 43.20M | 27.70M |
| Short long term debt | 0.90M | 0.00000M | 0.30M | 30.50M | 18.00M |
| Short long term debt total | 464.90M | 552.10M | 397.30M | 439.70M | 254.50M |
| Other stockholder equity | 420.20M | 420.20M | 464.40M | 280.60M | 200.90M |
| Property plant equipment | - | - | - | 112.00M | 80.30M |
| Total current assets | 608.10M | 588.90M | 488.20M | 429.00M | 293.70M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | - | - | -169.40000M | -72.70000M |
| Short term investments | - | - | - | - | 3.80M |
| Net receivables | 229.00M | 206.90M | 193.10M | 169.90M | 117.80M |
| Long term debt | 380.20M | 479.80M | 316.80M | 340.10M | 188.20M |
| Inventory | 297.40M | 280.10M | 232.70M | 217.40M | 139.80M |
| Accounts payable | 245.30M | 204.40M | 191.90M | 189.50M | 127.00M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -25.30000M | -17.20000M | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 49.10M | 1.50M | 6.80M | 6.40M | - |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 1248.70M | 1183.20M | 1101.10M | 950.00M | 689.70M |
| Capital lease obligations | 83.80M | 72.30M | 80.20M | 69.10M | 48.30M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
| Investments | - | -294.80000M | -270.90000M | -171.90000M | -448.40000M |
| Change to liabilities | - | - | - | 17.50M | 17.20M |
| Total cashflows from investing activities | -31.30000M | -294.80000M | - | -171.90000M | -448.40000M |
| Net borrowings | -112.50000M | 185.80M | - | 123.90M | 193.40M |
| Total cash from financing activities | -212.90000M | 90.30M | 107.50M | 64.40M | 139.70M |
| Change to operating activities | - | - | - | - | - |
| Net income | 283.70M | 207.40M | 183.30M | 144.30M | 104.30M |
| Change in cash | 26.20M | -6.90000M | 20.70M | 16.90M | -182.00000M |
| Begin period cash flow | 55.50M | 62.40M | 41.70M | 24.80M | 206.80M |
| End period cash flow | 81.70M | 55.50M | 62.40M | 41.70M | 24.80M |
| Total cash from operating activities | 267.60M | 198.10M | 189.20M | 125.00M | 116.10M |
| Issuance of capital stock | -4.10000M | -2.30000M | 234.20M | 2.80M | 0.60M |
| Depreciation | 30.50M | 32.20M | 28.60M | 23.90M | 20.70M |
| Other cashflows from investing activities | 0.30M | 4.90M | - | - | -442.20000M |
| Dividends paid | 80.70M | 76.80M | 70.50M | 56.20M | 52.90M |
| Change to inventory | -17.40000M | -7.70000M | 10.80M | -35.60000M | -13.50000M |
| Change to account receivables | -14.70000M | -18.50000M | - | -10.60000M | -16.30000M |
| Sale purchase of stock | -4.10000M | -2.30000M | - | 0.00000M | -0.60000M |
| Other cashflows from financing activities | -15.60000M | -16.40000M | 561.10M | 143.40M | 206.20M |
| Change to netincome | - | - | - | -7.30000M | 5.10M |
| Capital expenditures | 14.40M | 19.70M | 23.10M | 15.40M | 6.20M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -4.60000M | -8.50000M | -4.20000M | -28.70000M | -12.60000M |
| Stock based compensation | 6.20M | 7.10M | 4.10M | 2.80M | 1.80M |
| Other non cash items | -48.20000M | -40.10000M | 53.20M | -17.30000M | 44.50M |
| Free cash flow | 253.20M | 178.40M | 166.10M | 109.60M | 109.90M |
Sector: Industrials Industry: Industrial Distribution
| Company | Change (GBX) | Price (GBX) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| DPLM Diploma PLC |
50.00 0.71% | 7100.00 | 47.45 | 27.78 | 5.72 | 8.43 | 5.73 | 23.84 |
| FERG Ferguson Plc |
-210.0 1.23% | 16860.00 | 24.65 | 19.19 | 1.22 | 8.19 | 1.68 | 16.69 |
| RS1 RS GROUP PLC |
4.43 0.67% | 664.43 | 17.10 | 14.22 | 0.96 | 1.96 | 1.07 | 9.61 |
| GFTU Grafton Group plc |
12.20 1.49% | 831.20 | 12.59 | 8.53 | 0.70 | 0.92 | 0.69 | 4.19 |
| TPK Travis Perkins PLC |
8.50 1.58% | 546.50 | - | 17.73 | 0.27 | 0.66 | 0.39 | 20.87 |
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Europe, North America, and internationally. It operates through three business sectors: Controls, Seals, and Life Sciences. The Controls sector offers wire and cabling, interconnect, specialty fasteners, specialty adhesive and industrial automation solutions for various applications. The Seals sector supplies sealing and fluid power products, gaskets, hoses and fittings, pumps and valves, and solutions for aftermarket repairs, original equipment manufacturing, and maintenance, repair and overhaul projects. The Life Sciences sector supplies and services equipment; provides consumables and instrumentation for surgery, diagnosis of disease, and critical care support; and supplies diagnostic and scientific technologies, surgical instruments, medical devices, endoscopes, patient monitoring equipment, specialist hospital supplies, and clinical nutrition. It serves public and private hospitals, clinics and diagnostics laboratories. Diploma PLC was incorporated in 1999 and is based in London, the United Kingdom.
10-11 Charterhouse Square, London, United Kingdom, EC1M 6EE
| Name | Title | Year Born |
|---|---|---|
| Mr. Jonathan Thomson | CEO & Director | 1972 |
| Mr. Chris Davies | Interim Group Chief Financial Officer | 1970 |
| Mr. John Morrison | Group Company Sec. & Head of Legal | NA |
| Mr. Neil Yazdani | Group Financial Controller | NA |
| Mr. Stuart Bell | Fin. Director of International Seals | NA |
| Mr. Jonathan David Thomson | CEO & Director | 1972 |
| Mr. Wilson Ng | Group CFO, Group Financial Controller & Director | NA |
| Ms. Holly Gillis | Head of Investor Relations | NA |
| Ms. Anna Lawrence | Group General Counsel & Company Secretary | NA |
| Steve Sargeant | Group Corporate Development Director | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Please wait processing your request...